Synapse - Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens

Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens Meeting Abstract

Authors:	Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; Shekarkhand, T.; Rueda, C.; Zhang, Y.; Lahoud, O. B.; Shah, G. L.; Scordo, M.; Chung, D.; Landau, H.; Giralt, S. A.; Lesokhin, A.; Korde, N.; Usmani, S. Z.; Tan, C.
Abstract Title:	Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
Meeting Title:	65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	142
Issue:	Suppl. 1
Meeting Dates:	2023 Dec 9-12
Meeting Location:	San Deigo, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2023-11-02
Start Page:	2024
Language:	English
ACCESSION:	WOS:001159306707250
DOI:	10.1182/blood-2023-190728
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos